Handelsavisen
prelaunch
Companies Basic Materials SDCH.NS
SD
SDCH.NS NSE (India) Diversified Specialty Chemicals

Sudarshan Chemical Industries Ltd

$1 043,95
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,49 %
Op margin
3,8 %
ROE
1,6 %
Net margin
1,7 %
Debt / equity
0,69
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-11-09
Ex-dividend
TR 1Y
About

Sudarshan Chemical Industries Ltd is a specialty chemicals company that produces and sells a range of chemical products, primarily used in industrial applications.

Business. Sudarshan Chemical Industries Ltd (SDCH.NS) is a specialty chemicals manufacturer operating within the Basic Materials sector. The company is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification99 %
SectorBasic Materials
Industry groupDiversified Specialty Chemicals
Generated · model-assisted
Sell-side consensus
BUY5 analysts
4 buy0 hold1 sell
Avg 12m price target1 241,40

Analyst recommendations

5 analysts · consensus Buy
Buy4
Hold0
Sell1
12-month price target
1 241,40
Consensus of sell-side coverage.
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
5 analysts · indicative
Ownership
not yet wired
Profitability
1,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning SDCH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to SDCH.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Sudarshan Chemical Industries Ltd (SDCH.NS) is a specialty chemicals manufacturer operating within the Basic Materials sector. The company is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification99 %
    SectorBasic Materials
    Industry groupDiversified Specialty Chemicals
    AI synthesis
    GENERATED

    Sudarshan Chemical Industries Ltd has a debt-to-equity ratio of 0.69, indicating a moderate level of leverage, and a current ratio of 2.12, suggesting it has sufficient short-term assets to cover its liabilities. The company's liquidity position is assessed as medium, with free cash flow of 1,226.23 million INR and operating cash flow of 370.37 million INR, but net cash is negative after subtracting total debt.

    In terms of profitability, the company's return on equity is 1.62%, and return on assets is 0.57%, both of which are below the typical thresholds for strong performance in the specialty chemicals industry. The operating margin is 3.84%, and the net profit margin is 1.67%, indicating that the company is generating modest returns on its operations.

    The company's revenue is primarily concentrated in a single business segment, with no significant geographic diversification reported in the available data. This concentration may expose the company to higher risks if demand in its primary market fluctuates.

    Looking at the growth trajectory, the company's revenue for the latest period is 33,455.75 million INR. While specific growth projections for the next fiscal year are not provided, the company's capital expenditure of -945.66 million INR suggests a reduction in investment in new projects or facilities.

    The risk assessment indicates a low potential for dilution, with no significant dilution sources identified in the latest filings or disclosures. However, the company's liquidity risk is moderate due to its negative net cash position after accounting for total debt.

    Recent events and filings do not indicate any major changes in the company's operations or strategic direction. The company's stock has a mean price target of 1,241.40 INR and a median price target of 1,247.00 INR, with a mean recommendation of 2.00, indicating a generally positive outlook from analysts.

    Key takeaways
    • The company has a moderate level of leverage with a debt-to-equity ratio of 0.69.
    • The company's return on equity and return on assets are below typical industry thresholds.
    • The company's revenue is concentrated in a single business segment, which may increase its exposure to market fluctuations.
    • The company's liquidity position is assessed as medium, with a current ratio of 2.12.
    • The company's stock has a positive outlook from analysts, with a mean price target of 1,241.40 INR.
    • **margin_outlook_rationale**: The company's operating margin is 3.84%, and the net profit margin is 1.67%, indicating modest returns on operations.
    • **rd_outlook_rationale**: No specific information is provided regarding the company's research and development activities or outlook.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1 043,95
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $34.40B
    Net cash
    -$22.16B
    Current ratio
    2.1
    Debt / equity
    0.7
    ROA
    0.6%
    ROE
    1.6%
    Cash conversion
    66.0%
    CapEx / revenue
    -2.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    5,57
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-23 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate5,57
    Revenueno estimateno estimate93,9B INR
    Operating incomeno estimateno estimate1,4B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy3
    Buy1
    Hold0
    Sell0
    Strong sell1
    12-month price target$1 241,40 · Median $1 247,00
    Low $1 047,00High $1 420,00
    Operating income · consensus1,4B INR
    EPS surprise
    +304,2 %
    reported vs consensus · beat
    Revenue surprise
    −64,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$1 047,00
    Mean$1 241,40
    Median$1 247,00
    High$1 420,00
    Spot$1 043,95
    +18.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin3,8 %Below median
    Net Margin1,7 %Below median
    ROE1,6 %Below median
    Capex / Rev-2,8 %Below median
    D/E0,69Below median
    Cash Conv0,66Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Sudarshan Chemical Industries Ltd Market data — financials · 2026-05-29
    • Sudarshan Chemical Industries Ltd Market data — analyst estimates · 2026-05-29
    • Sudarshan Chemical Industries Ltd Market data — ESG · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    200shares short-4.8% vs prior
    1days to cover
    100fails-to-deliver
    as of 2026-05-29 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    SDCH.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Debt-to-equity (FY 2025-12-31): 0.61xDerived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 1.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -29.5%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -20.2%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 3,250.0%Derived (calculated)
    • Current ratio (FY 2025-12-31): 1.42xDerived (calculated)
    • Shares outstanding (annual): 4.45MSEC XBRL filing
    • Cash & equivalents (annual): USD 201KSEC XBRL filing
    • Total assets (annual): USD 2.98MSEC XBRL filing
    • Shareholders' equity (annual): USD 1.85MSEC XBRL filing
    • Current assets (annual): USD 1.61MSEC XBRL filing
    • Current liabilities (annual): USD 1.13MSEC XBRL filing
    • Total liabilities (annual): USD 1.13MSEC XBRL filing
    • Net income (YoY) (2025-09-30 vs 2024-09-30): 1.3%Derived (calculated)
    • Net margin (FY 2025-09-30): -12.1%Derived (calculated)
    • Gross margin (FY 2025-09-30): 47.7%Derived (calculated)
    • Cost of revenue (YoY) (2025-09-30 vs 2024-09-30): -0.5%Derived (calculated)
    • Gross profit (YoY) (2025-09-30 vs 2024-09-30): -0.8%Derived (calculated)
    • Operating cash flow (YoY) (2025-09-30 vs 2024-09-30): -142.3%Derived (calculated)
    • Operating income (YoY) (2025-09-30 vs 2024-09-30): 2.3%Derived (calculated)
    • R&D expense (YoY) (2025-09-30 vs 2024-09-30): 2.9%Derived (calculated)
    • Revenue (YoY) (2025-09-30 vs 2024-09-30): -0.7%Derived (calculated)
    • Pre-tax income (annual): USD -878KSEC XBRL filing
    • Total operating expenses (annual): USD 4.42MSEC XBRL filing
    Showing 24 of 54 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-11-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage